Periodic Reporting for period 5 - PREFER (Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966)

Summary
As of today, there is no generally accepted set of guidelines or recommendations on when and how to elicit patient preference information that is ready for medical decision making. As one of the most highly ranked requirements that was shared by decision makers in the IMI...
More information & hyperlinks
Web resources: http://www.imi-prefer.eu